GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofil Chemicals & Pharmaceuticals Ltd (NSE:BIOFILCHEM) » Definitions » Receivables Turnover

Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Receivables Turnover : 0.26 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biofil Chemicals & Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Biofil Chemicals & Pharmaceuticals's Revenue for the three months ended in Jun. 2024 was ₹84.4 Mil. Biofil Chemicals & Pharmaceuticals's average Accounts Receivable for the three months ended in Jun. 2024 was ₹330.3 Mil. Hence, Biofil Chemicals & Pharmaceuticals's Receivables Turnover for the three months ended in Jun. 2024 was 0.26.


Biofil Chemicals & Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for Biofil Chemicals & Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biofil Chemicals & Pharmaceuticals Receivables Turnover Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.42 1.52 1.84 2.17 1.50

Biofil Chemicals & Pharmaceuticals Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.63 0.18 0.46 0.26

Competitive Comparison of Biofil Chemicals & Pharmaceuticals's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofil Chemicals & Pharmaceuticals's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's Receivables Turnover falls into.



Biofil Chemicals & Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Biofil Chemicals & Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Receivables Turnover (A: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2024 ) / ((Accounts Receivable (A: Mar. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count )
=400.353 / ((205.027 + 330.291) / 2 )
=400.353 / 267.659
=1.50

Biofil Chemicals & Pharmaceuticals's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

Receivables Turnover (Q: Jun. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Jun. 2024 ) / ((Accounts Receivable (Q: Mar. 2024 ) + Accounts Receivable (Q: Jun. 2024 )) / count )
=84.434 / ((330.291 + 0) / 1 )
=84.434 / 330.291
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biofil Chemicals & Pharmaceuticals  (NSE:BIOFILCHEM) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Biofil Chemicals & Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Biofil Chemicals & Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Biofil Chemicals & Pharmaceuticals Business Description

Traded in Other Exchanges
Address
11/12, Sector E, Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian-based pharmaceutical company. The company's operating segment includes Pharma and Chemicals. It generates maximum revenue from the Pharma segment.

Biofil Chemicals & Pharmaceuticals Headlines

No Headlines